• Explore /
  • Poster
  • / A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub-study SWOG S1400C.

A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub-study SWOG S1400C.

Abstract Poster

Authors

Martin Edelman

Martin J. Edelman

Fox Chase Cancer Center, Philadelphia, PA

Martin J. Edelman , Mary Weber Redman , Kathy S. Albain , Eric C. McGary , Norman Rafique , Daniel P. Petro , Saiama Naheed Waqar , Jieling Miao , Katie Griffin , Vassiliki Papadimitrakopoulou , Karen Kelly , David R. Gandara , Roy S. Herbst

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02785939

Citation

J Clin Oncol 35, 2017 (suppl; abstr 9056)

DOI

10.1200/JCO.2017.35.15_suppl.9056

Abstract #

9056

Poster Bd #

382

Abstract Disclosures

Similar Posters

First Author: Giorgio V. Scagliotti

First Author: Laurien Joanna Zeverijn

First Author: Sukhmani Kaur Padda

First Author: Jonathan D Sorah